tirzepatide ckd in CKD: FDA, ADA, EASD, RSSDI Guidance | Paramesh Shamanna posted on the topic Multidimensional Predictors of Tirzepatide Efficacy:

I think, again, its all about the long term benefits because the benefits on the cardiovascular system and risk the benefits on weight loss, the benefits on, you know, the heart and metabolism far outweigh, I think, side effects that can be managed

First, which day of the week do you have the most flexibility and the least obligations

Because I have worked in a wonderful organization of people who can do these large scale clinical trials, and we used to not collect a lot of samples for future use, but we've done that for some years now

Small, regular investments in movement, sleep, nutrition, and supportive routines are the reliable engine of lasting change

Whilst diarrhea occurs in up to 20% of patients treated with GLP-1RA, 118 national registry studies from Denmark, 89 Israel, 92 and the USA, 93 collectively involving over 10 000 patients with IBD, found no indication that GLP-1RA use was associated with worsening of IBD symptoms or increased adverse event rates